Fallopian tube cancer – Treatment

Go back

Fallopian tube cancer is a rare disease that affects the tubes connecting the ovaries to the uterus, and because it often shows no symptoms in its early stages, treatment focuses on removing the cancer surgically and using medications to control the disease, improve quality of life, and prevent it from returning.

Understanding Treatment Goals and Approaches

When someone is diagnosed with fallopian tube cancer, the main goals of treatment are to remove as much cancer as possible, control the disease if it has spread, manage symptoms, and help the patient maintain the best possible quality of life. Treatment decisions depend heavily on how far the cancer has spread, which is determined by its stage, as well as the patient’s overall health and personal preferences.[1]

Medical teams use approaches that have been proven effective through years of clinical experience and research. These standard treatments are recommended by medical societies and include surgery, chemotherapy, and other medications. At the same time, researchers around the world are studying new therapies in clinical trials to find better ways to treat this disease. These trials test innovative drugs and treatment methods that may one day become standard care.[3]

Because fallopian tube cancer is rare and behaves very similarly to ovarian cancer, doctors treat them in the same way. In fact, many cancers once thought to start in the ovaries actually begin in the fallopian tubes, particularly at the end of the tube near the ovary. This understanding has shaped how doctors approach treatment for both conditions.[1][7]

The challenge with fallopian tube cancer is that it often spreads quickly and doesn’t cause noticeable symptoms until it has already moved beyond the tubes. This means many people are diagnosed at an advanced stage, when the cancer is harder to treat. However, if caught early, when surgery can remove all the cancer cells, the disease can be curable.[1]

Standard Treatment Approaches

Surgery as the First Step

Surgery is typically the first and most important part of treating fallopian tube cancer. The operation aims to remove all visible cancer from the body. In most cases, this means performing a hysterectomy, which is the removal of the uterus, along with a salpingectomy (removal of the fallopian tubes) and an oophorectomy (removal of the ovaries). Because the cancer often spreads to nearby organs, the surgeon may also need to remove the omentum, a fatty tissue that hangs over the intestines, and sample or remove nearby lymph nodes to check if cancer has spread there.[1][5]

During surgery, the doctor will take washings from the abdomen and pelvis to look for cancer cells in the fluid. This helps determine how far the cancer has spread. The surgical team will also examine the entire abdomen and pelvis carefully to see if cancer is present in other areas. All of this information helps to determine the stage of the cancer, which guides further treatment decisions.[5]

In advanced cases where the cancer has spread to other organs and cannot be completely removed, doctors perform what is called cytoreductive surgery or debulking. The goal here is to remove as much of the tumor as possible, leaving only small amounts of cancer behind. This makes subsequent treatments, like chemotherapy, more effective because there is less cancer for the drugs to fight.[5]

Chemotherapy After Surgery

After surgery, most patients receive chemotherapy, which uses powerful drugs to kill cancer cells or stop them from growing. Chemotherapy is typically recommended as follow-up treatment because even when surgery appears to have removed all visible cancer, microscopic cancer cells may remain and could eventually grow back.[8]

The most commonly used chemotherapy drugs for fallopian tube cancer are platinum-based medications, particularly those containing carboplatin or cisplatin, often combined with another drug called paclitaxel (also known by the brand name Taxol). These medications are usually given through an intravenous line directly into the bloodstream. Treatment is typically given in cycles, with a treatment period followed by a rest period to allow the body to recover. Most patients receive chemotherapy for several months.[14][16]

Chemotherapy can cause various side effects because it affects not only cancer cells but also some normal, rapidly dividing cells in the body. Common side effects include nausea, vomiting, fatigue, loss of appetite, hair loss, and increased risk of infections because the drugs can lower the number of white blood cells. Some chemotherapy drugs, particularly those containing platinum, can cause peripheral neuropathy, which is numbness, tingling, or pain in the fingers and toes. Paclitaxel can cause muscle and joint aches and leg weakness.[18]

Many of these side effects can be managed with supportive medications. For example, anti-nausea drugs can help control nausea and vomiting, and medications can be given to help the body produce more white blood cells. Most side effects improve after chemotherapy is finished, though some, like peripheral neuropathy, may take months to resolve or can become permanent in some cases.[18]

⚠️ Important
It’s important to tell your healthcare team about any side effects you experience during treatment. Many side effects can be managed or reduced with medications or adjustments to your treatment plan. Don’t wait until side effects become severe—early intervention often works better. Your medical team wants to help you feel as comfortable as possible during treatment.

Targeted Therapy and Maintenance Treatment

After completing initial chemotherapy, some patients may be eligible for maintenance therapy, which aims to keep the cancer from coming back or to delay its return. One type of maintenance therapy uses drugs called PARP inhibitors. These medications work by blocking an enzyme that helps cells repair their DNA. Cancer cells with certain genetic mutations, particularly in the BRCA1 or BRCA2 genes, have difficulty repairing DNA damage. When PARP inhibitors are added, it becomes even harder for these cancer cells to survive, and they die.[18]

Patients who have a BRCA mutation, which can be identified through genetic testing, are particularly good candidates for PARP inhibitors. These drugs are typically taken as pills daily for about two years after chemotherapy is completed. The goal is to keep patients in remission, which means there is no evidence of cancer in the body.[18]

Another type of targeted therapy sometimes used is bevacizumab (brand name Avastin), which is a type of drug called an angiogenesis inhibitor. This medication works by blocking the formation of new blood vessels that tumors need to grow. It can be given along with chemotherapy and then continued as maintenance therapy.[14]

Other Treatment Options

In some situations, doctors may use additional treatments. Radiation therapy, which uses high-energy rays to kill cancer cells, is not commonly used for fallopian tube cancer but may be helpful in specific situations, such as treating cancer that has spread to a particular area or relieving symptoms like pain.[3]

Hormone therapy may be an option for some patients, particularly those whose cancer has certain hormone receptors. This treatment uses medications that block hormones or lower hormone levels to slow or stop cancer growth.[3]

Treatment Being Studied in Clinical Trials

Understanding Clinical Trial Phases

Clinical trials are research studies that test new treatments to see if they are safe and effective. These trials happen in different phases, each designed to answer specific questions. Phase I trials test a new drug or treatment in a small group of people to evaluate its safety, determine safe dosage ranges, and identify side effects. Phase II trials involve more participants and aim to see if the treatment actually works against the cancer while continuing to monitor safety. Phase III trials compare the new treatment to the current standard treatment in large groups of patients to see which works better.[10]

For patients with fallopian tube cancer, participating in a clinical trial may provide access to promising new treatments that are not yet widely available. Researchers are constantly working to develop better therapies with fewer side effects and improved outcomes.[10]

Innovative Therapies Under Investigation

Several types of innovative treatments are currently being studied for fallopian tube cancer and related gynecologic cancers. Because fallopian tube cancer is treated like ovarian cancer, many trials that study ovarian cancer treatments also include patients with fallopian tube cancer.[10]

Immunotherapy is one of the most exciting areas of cancer research. These treatments work by helping the patient’s own immune system recognize and attack cancer cells. The immune system normally protects the body from infections and diseases, but cancer cells can sometimes hide from it. Immunotherapy drugs help remove this disguise, allowing the immune system to do its job. Different types of immunotherapy are being tested, including checkpoint inhibitors, which release the brakes on the immune system, and cancer vaccines, which train the immune system to recognize specific cancer cells.[16]

Researchers are also studying new targeted therapies that attack specific weaknesses in cancer cells. For example, some trials are testing drugs that target specific genetic mutations or proteins that cancer cells need to grow and survive. These treatments are often more precise than traditional chemotherapy because they specifically target cancer cells while leaving normal cells relatively unharmed.[16]

New combinations of existing drugs are also being tested. Scientists are exploring whether combining different types of targeted therapies, or combining targeted therapies with chemotherapy or immunotherapy, might work better than any single treatment alone. These combination approaches aim to attack cancer from multiple angles simultaneously.[10]

Gene Therapy and Personalized Medicine

As understanding of the genetic basis of cancer improves, researchers are developing treatments tailored to the specific genetic makeup of each patient’s tumor. This approach, called personalized medicine or precision medicine, involves testing the tumor for specific genetic changes and then choosing treatments that target those particular changes. Some clinical trials are testing new drugs that target specific genetic mutations found in fallopian tube cancer.[10]

For example, because many fallopian tube cancers have mutations in genes involved in DNA repair, researchers are studying new ways to exploit these weaknesses. Beyond PARP inhibitors, which are already approved, scientists are testing other drugs that target DNA repair pathways or that work better in combination with PARP inhibitors.[10]

Trial Locations and Eligibility

Clinical trials for fallopian tube cancer are conducted at major cancer centers and research hospitals around the world, including in the United States, Europe, and other regions. Many of these trials are conducted at comprehensive cancer centers that specialize in gynecologic cancers.[10]

Not every patient is eligible for every trial. Eligibility depends on many factors, including the stage and type of cancer, previous treatments received, overall health, and specific characteristics of the tumor. Some trials are looking for patients who have just been diagnosed and haven’t received treatment yet, while others are for patients whose cancer has come back after previous treatment. Patients interested in clinical trials should talk to their doctor, who can help identify appropriate trials and determine if they meet the eligibility criteria.[10]

Most Common Treatment Methods

  • Surgery
    • Total abdominal hysterectomy removes the uterus and cervix
    • Bilateral salpingo-oophorectomy removes both fallopian tubes and ovaries
    • Omentectomy removes the fatty tissue covering the intestines
    • Lymph node sampling checks if cancer has spread to nearby lymph nodes
    • Cytoreductive surgery removes as much visible tumor as possible in advanced cases
    • Peritoneal washings collect fluid from the abdomen to check for cancer cells
  • Chemotherapy
    • Platinum-based drugs like carboplatin or cisplatin kill rapidly dividing cancer cells
    • Paclitaxel (Taxol) stops cancer cells from dividing by affecting their internal structure
    • Combination therapy uses two or more drugs together for better effectiveness
    • Treatment typically given in cycles over several months
    • Can be administered intravenously or sometimes directly into the abdomen
  • Targeted Therapy
    • PARP inhibitors block DNA repair in cancer cells with BRCA mutations
    • Bevacizumab prevents formation of blood vessels that feed tumors
    • Often used as maintenance therapy after initial chemotherapy
    • May be taken as daily pills for up to two years
  • Immunotherapy
    • Checkpoint inhibitors help the immune system recognize cancer cells
    • Under investigation in clinical trials for gynecologic cancers
    • May be combined with other treatments for better results
  • Hormone Therapy
    • Uses medications to block hormones or lower hormone levels
    • May be option for cancers with hormone receptors
    • Can help slow or stop cancer growth in selected patients
  • Radiation Therapy
    • Uses high-energy rays to kill cancer cells
    • Not commonly used but may help in specific situations
    • Can treat cancer that has spread to particular areas
    • May be used to relieve symptoms like pain

Managing Treatment Side Effects

Living with and recovering from fallopian tube cancer treatment involves managing both short-term and long-term side effects. The good news is that many side effects can be controlled with proper care and support from your medical team.[18]

Short-term side effects from chemotherapy typically include nausea, vomiting, fatigue, hair loss, and decreased appetite. These usually improve once treatment is completed, though it can take time. Some patients experience “chemo brain,” which is difficulty with memory, concentration, and thinking clearly. This can last for several months after treatment ends but generally improves over time.[18]

Bowel problems are common both during and after treatment because fallopian tube cancer often affects the intestines. Some patients experience constipation, while others have diarrhea. Your healthcare team can work with you to develop an individualized bowel management plan that may include stool softeners, dietary changes, or medications to control diarrhea. In rare cases, patients may develop a bowel obstruction, which is a serious condition requiring immediate medical attention. Warning signs include inability to have a bowel movement along with nausea or vomiting.[18]

Peripheral neuropathy, the numbness and tingling in hands and feet caused by some chemotherapy drugs, can be particularly bothersome. For some patients, this improves within months after treatment ends, but for others it may be permanent. Your healthcare team can suggest strategies to cope with this, such as being extra careful with hot items to avoid burns or using assistive devices if balance is affected.[18]

It’s important to understand that full recovery from chemotherapy can take time. You may not feel like yourself right away, and it can take up to a year to regain your normal energy level and for your body to fully recover from the effects of treatment.[18]

When Cancer Returns

Unfortunately, fallopian tube cancer has a high rate of recurrence, meaning it may come back after initial treatment. Recurrence occurs in more than 80% of patients with advanced ovarian and fallopian tube cancers. The cancer may return in the same area where it started or in other parts of the body.[20]

After completing treatment, patients typically have regular follow-up appointments to monitor for signs of recurrence. These visits may include physical examinations, blood tests to check tumor marker levels (such as CA-125), and imaging tests. The frequency of these appointments is usually higher in the first few years after treatment and may decrease over time.[20]

Symptoms that may indicate recurrence include abdominal pain, swelling or bloating, changes in bowel movements, fatigue, pelvic or lower back pain, and urinary problems. It’s important to report any new or persistent symptoms to your healthcare team right away, even if you’re not due for a scheduled appointment.[20]

If cancer does recur, treatment options depend on several factors, including where the cancer has returned, how much time has passed since initial treatment, and the patient’s overall health. Some patients may undergo additional surgery if the cancer is localized. Others may receive different chemotherapy drugs or participate in clinical trials testing new treatments.[10]

Advanced cancer that has come back usually cannot be cured, but treatment can often control it and relieve symptoms for many months or even years. The focus of treatment shifts to maintaining quality of life, managing symptoms, and keeping the cancer under control for as long as possible.[17]

⚠️ Important
Living with the fear of recurrence is one of the most difficult emotional challenges for cancer survivors. This fear is normal and understandable. Consider talking to a counselor, therapist, or joining a support group where you can share your feelings with others who understand what you’re going through. Taking care of your mental health is just as important as taking care of your physical health.

Living Well After Treatment

Life after fallopian tube cancer treatment brings both challenges and opportunities. Many survivors find that making healthy lifestyle choices helps them feel better and may improve their overall health. This includes eating a balanced diet, staying physically active within your abilities, getting enough rest, and staying hydrated. Talk to your doctor about what level of physical activity is appropriate for you.[20]

Building a strong support network is crucial. This might include family and friends, professional counselors or therapists, support groups for cancer survivors, and advocacy organizations focused on gynecologic cancers. Many patients find it helpful to connect with others who have been through similar experiences, either through in-person support groups or online forums.[20]

It’s important to honor your feelings throughout this journey. Cancer and its treatment can bring up a wide range of emotions including frustration, sadness, anger, guilt, anxiety, and exhaustion. All of these feelings are valid and normal. Give yourself permission to feel whatever emotions arise, and don’t hesitate to reach out for support when you need it. Staying in close contact with your healthcare team and letting them know how you’re feeling emotionally as well as physically is important.[20]

Some patients find it helpful to focus on staying present and maintaining hope while also being realistic about their situation. Creating daily routines, setting small achievable goals, and finding activities that bring joy and meaning can help maintain a positive outlook. This might include reconnecting with loved ones, pursuing hobbies or interests, or simply setting aside time for self-care.[20]

Ongoing Clinical Trials on Fallopian tube cancer

  • Phase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients

    Recruiting

    3 1 1 1
    Austria Belgium Czechia Denmark France Germany +9
  • Study of ubamatamab alone or with cemiplimab for adults with ovarian, fallopian tube, peritoneal, or endometrial cancer that has come back

    Recruiting

    2 1 1 1
    Belgium France Italy The Netherlands Spain
  • Study of TORL-1-23 and pegfilgrastim in women with advanced platinum-resistant ovarian, peritoneal, or fallopian tube cancer expressing CLDN6

    Recruiting

    2 1 1 1
    Investigated diseases:
    Austria Belgium Czechia France Germany Ireland +2
  • Study of Relacorilant, Nab-Paclitaxel, and Bevacizumab for Patients with Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer

    Recruiting

    2 1 1 1
    Belgium France Germany Italy Poland Spain
  • Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium Bulgaria Czechia France Germany Hungary +6
  • Study on Olaparib and Bevacizumab for Patients with Advanced Ovarian, Fallopian Tube, or Peritoneal Cancer

    Recruiting

    2 1 1 1
    Investigated drugs:
    Spain
  • Study on Niraparib and Dostarlimab for Patients with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Not Suitable for Platinum Treatment

    Recruiting

    3 1 1 1
    Czechia France Germany Italy
  • Study on Niraparib, Carboplatin, and Paclitaxel for Advanced Ovarian Cancer Patients After Tumor Removal

    Recruiting

    2 1 1 1
    Austria Belgium Czechia Germany Italy Spain
  • Study on the Safety and Effectiveness of REGN5668 with Cemiplimab or Ubamatamab for Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    Recruiting

    2 1 1 1
    Belgium France Spain
  • Study on Bevacizumab Dose Equivalence for Patients with Ovarian, Fallopian Tube, or Peritoneal Cancer Using Bevacizumab, Olaparib, Carboplatin, and Paclitaxel

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Poland

References

https://my.clevelandclinic.org/health/diseases/21540-fallopian-tube-cancer

https://www.mdanderson.org/cancer-types/fallopian-tube-cancer.html

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/types/fallopian-tube

https://www.ucsfhealth.org/conditions/fallopian-tube-cancer

https://en.wikipedia.org/wiki/Fallopian_tube_cancer

https://www.macmillan.org.uk/cancer-information-and-support/ovarian-cancer/fallopian-tube-cancer

https://www.cancer.gov/news-events/cancer-currents-blog/2017/ovarian-cancer-fallopian-tube-origins

https://www.loyolamedicine.org/services/cancer/cancer-conditions/fallopian-tube-tubal-cancer

https://my.clevelandclinic.org/health/diseases/21540-fallopian-tube-cancer

https://www.cancer.gov/types/ovarian/patient/ovarian-epithelial-treatment-pdq

https://hollingscancercenter.musc.edu/news/archive/2023/02/13/gynecologic-oncologist-explains-how-removing-fallopian-tubes-can-prevent-ovarian-cancer

https://www.oncolink.org/cancers/gynecologic/fallopian-tube-cancer/fallopian-tube-cancer-staging-and-treatment

https://cancer.uthscsa.edu/cancer-care/conditions/fallopian-tube-cancer

https://www.mayoclinic.org/diseases-conditions/ovarian-cancer/diagnosis-treatment/drc-20375946

https://www.roswellpark.org/cancer/fallopian-tube/treatment

https://www.cancer.org/cancer/types/ovarian-cancer/treating.html

https://www.cancerresearchuk.org/about-cancer/ovarian-cancer/living-with/coping-if-your-cancer-cant-be-cured

https://cancerblog.mayoclinic.org/2023/10/04/life-after-ovarian-cancer-coping-with-side-effects-fear-of-recurrence-and-finding-support/

https://www.cancer.org/cancer/types/ovarian-cancer/after-treatment.html

https://ourwayforward.com/ovarian-cancer/living-with-ovarian-cancer/

https://my.clevelandclinic.org/health/diseases/21540-fallopian-tube-cancer

FAQ

Can fallopian tube cancer be detected early?

Early detection is challenging because fallopian tube cancer often causes no symptoms in its early stages. There is no effective screening test for fallopian tube cancer in the general population. However, women at high risk due to BRCA gene mutations may undergo preventive surgery to remove the tubes and ovaries, which can detect very early cancers or precancerous changes.

How is fallopian tube cancer different from ovarian cancer?

Fallopian tube cancer and ovarian cancer are very similar diseases. In fact, most of what was previously called ovarian cancer likely starts in the fallopian tubes. Because they behave the same way, grow in the same type of tissue, and spread similarly, doctors treat them using the same approaches. The main difference is simply where the cancer cells first develop.

Will I be able to have children after treatment for fallopian tube cancer?

Standard treatment for fallopian tube cancer involves removing the uterus, both fallopian tubes, and both ovaries, which makes pregnancy impossible afterward. This is necessary because the cancer typically affects these organs and can spread between them. Women who haven’t gone through menopause should discuss this with their doctor before treatment, though fertility-sparing surgery is rarely an option for this type of cancer.

Should my family members be tested if I have fallopian tube cancer?

If you have fallopian tube cancer, especially if you’re diagnosed at a younger age or have a family history of breast or ovarian cancer, genetic testing may reveal an inherited mutation such as in the BRCA1 or BRCA2 genes. If you have an inherited mutation, your blood relatives (siblings, children, parents) may also carry it and could benefit from genetic counseling and testing. Talk to your doctor about whether genetic testing is recommended in your situation.

What is maintenance therapy and do I need it?

Maintenance therapy is treatment given after completing initial chemotherapy to help keep cancer from returning or to delay its return. Not everyone needs maintenance therapy. PARP inhibitors are a type of maintenance therapy typically offered to patients with BRCA gene mutations or certain other genetic characteristics. Your doctor will discuss whether maintenance therapy is appropriate based on your specific situation, genetic test results, and how well you responded to initial treatment.

🎯 Key Takeaways

  • Fallopian tube cancer is treated similarly to ovarian cancer because they are essentially the same disease starting in different but connected locations.
  • Surgery to remove the uterus, fallopian tubes, and ovaries is the cornerstone of treatment, often followed by chemotherapy to kill any remaining cancer cells.
  • Women with BRCA gene mutations may benefit from PARP inhibitor maintenance therapy, which can help prevent cancer from returning for up to two years after chemotherapy.
  • Clinical trials offer access to innovative treatments like immunotherapy and new targeted therapies that may provide better outcomes with fewer side effects.
  • Recovery from chemotherapy takes time—up to a year for full recovery of energy and body functions is normal and expected.
  • More than 80% of patients with advanced fallopian tube cancer experience recurrence, making regular follow-up appointments essential for early detection.
  • Even when cancer cannot be cured, treatment can often control the disease and relieve symptoms for many months or years, focusing on quality of life.
  • Building a strong support network including family, friends, healthcare providers, and cancer support groups helps with both the physical and emotional challenges of treatment and recovery.